The GPI-Linked Protein LY6A Drives AAV-PHP.B Transport across the Blood-Brain Barrier
2019 · Molecular Therapy · 216 citations
https://doi.org/10.1016/j.ymthe.2019.02.013
P
Peter Bell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
120
Papers
8.1K
Citations
51
h-index
87
i10-index
Peter Bell is an academic researcher from Integrated BioTherapeutics (United States). The author has contributed to research in topics: Virus-based gene therapy research & RNA Interference and Gene Delivery & CRISPR and Genetic Engineering. The author has an h-index of 51, co-authored 102 publications.
ORCID: 0000-0002-5420-4477Papers by this author
worksAnalysis of Tumors Arising in Male B6C3F1 Mice with and without AAV Vector Delivery to Liver
2006 · Molecular Therapy · 149 citations
https://doi.org/10.1016/j.ymthe.2006.03.008
Integrated vector genomes may contribute to long-term expression in primate liver after AAV administration
2023 · Nature Biotechnology · 124 citations
https://doi.org/10.1038/s41587-023-01974-7
AAV8-mediated Hepatic Gene Transfer in Infant Rhesus Monkeys (Macaca mulatta)
2011 · Molecular Therapy · 103 citations
https://doi.org/10.1038/mt.2011.151
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV Capsids
2015 · Molecular Therapy · 103 citations
https://doi.org/10.1038/mt.2015.179
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus Macaques
2018 · Molecular Therapy — Methods & Clinical Development · 101 citations
https://doi.org/10.1016/j.omtm.2018.06.003
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat